CEL-SCI CORPORATION Convertible Notes Payable
CEL-SCI CORPORATION (CVM) had Convertible Notes Payable of $0 as of 2012-06-30, per its 10-Q filed 2012-08-09.
Discontinued › Balance Sheet › Liabilities › Debt
us-gaap:ConvertibleNotesPayable · last filed 2012-12-14
- 2012-06-30: Convertible Notes Payable $0.00.
- 2012-03-31: Convertible Notes Payable $0.00.
- 2011-12-31: Convertible Notes Payable $2.96M.
- 2011-09-30: Convertible Notes Payable $5.00M.
| Period end | Convertible Notes Payable |
|---|---|
| 2012-06-30 | $0.00 10-Q · filed 2012-08-09 |
| 2012-03-31 | $0.00 10-Q · filed 2012-05-10 |
| 2011-12-31 | $2.96M 10-Q · filed 2012-02-09 |
| 2011-09-30 | $5.00M 10-K · filed 2012-12-14 |
| 2011-06-30 | $4.93M 10-Q · filed 2011-08-09 |
| 2010-09-30 | $0.00 10-K · filed 2011-12-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |